Original Research

Published on 25 Apr 2024

To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment

in Cancer Immunity and Immunotherapy

Zhou Yehan
Qin Sheng
Yang Hong
Li Jiayu
Hou Jun
Ji Juan
Shi Min
Yan Jiaxin
Hu Shangzhi
Wang Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1312380

Original Research

Published on 25 Apr 2024

Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor

in Cancer Immunity and Immunotherapy

Kayla Myers Chen
Daniel Grun
Brian Gautier
Shivaprasad Venkatesha
Michael Maddox
Ai-Hong Zhang
Peter Andersen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380065

Original Research

Published on 25 Apr 2024

The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study

in Alloimmunity and Transplantation

Tobias Heigl
Janne Kaes
Celine Aelbrecht
Jef Serré
Yoshito Yamada
Vincent Geudens
Anke Van Herck
Arno Vanstapel
Annelore Sacreas
Sofie Ordies

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369536

Editorial

Published on 25 Apr 2024

Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Giandomenico Roviello
Ismaela Anna Vascotto
Martina Catalano

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415608

Case Report

Published on 25 Apr 2024

Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study

in Cancer Immunity and Immunotherapy

José Mordoh
Erika Schwab
Alicia Inés Bravo
Mariana Aris
María Marcela Barrio

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354710

Original Research

Published on 25 Apr 2024

Exploring disease-specific metabolite signatures in hereditary angioedema patients

in Primary Immunodeficiencies

Adine Kanepa
Jingzhi Fan
Dmitrijs Rots
Annija Vaska
Laura Ansone
Monta Briviba
Janis Klovins
Natalja Kurjane
Kristaps Klavins

Frontiers in Immunology

doi 10.3389/fimmu.2024.1324671

Original Research

Published on 25 Apr 2024

Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Jiwei Zhang
Xiaotong Hou
Liting Wei
Jinshun Liu
Shibo Li
Yifan Guo
Hongbo Liu
Yan Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1345953

Brief Research Report

Published on 25 Apr 2024

Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs

in Comparative Immunology

Miriam Pedrera
Rebecca K. McLean
Lobna Medfai
Nazia Thakur
Shawn Todd
Glenn Marsh
Dalan Bailey
Gaetano Donofrio
Hiromi Muramatsu
Norbert Pardi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384417

138 views

Original Research

Published on 25 Apr 2024

Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion

in Molecular Innate Immunity

Ann-Sophie Damm
Flavia Reyer
Luisa Langhoff
Yi-Pin Lin
Franco Harald Falcone
Peter Kraiczy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390468

123 views

Original Research

Published on 25 Apr 2024

KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes’ phenotypes

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Teresina Laragione
Carolyn Harris
Percio S. Gulko

Frontiers in Immunology

doi 10.3389/fimmu.2024.1323410

Original Research

Published on 25 Apr 2024

Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer

in Cancer Immunity and Immunotherapy

Yilun Li
Xiaolu Yang
Cuizhi Geng
Yunjiang Liu
Tiantian Tang
Lina Zhang
Fei Liu
Meng Zhang
Jun Hao
Li Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390261

Review

Published on 25 Apr 2024

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges

in Cancer Immunity and Immunotherapy

Jun Chang Kong
Mohammad Auwal Sa’ad
Hema Manusri Vijayan
Manickam Ravichandran
Venugopal Balakrishnan
Seng Kong Tham
Gee Jun Tye

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384039

Review

Published on 25 Apr 2024

Exosomal PD-L1 in cancer and other fields: recent advances and perspectives

in Cancer Immunity and Immunotherapy

Man-Man Lu
Yu Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395332

Original Research

Published on 25 Apr 2024

Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems

in Cancer Immunity and Immunotherapy

Martina Schuster
Frank K. Braun
Dapi Meng-Lin Chiang
Christina Ludwig
Chen Meng
Christian Grätz
Benedikt Kirchner
Martin Proescholdt
Peter Hau
Ortrud K. Steinlein

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388769

Original Research

Published on 25 Apr 2024

EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells

in Cancer Immunity and Immunotherapy

Gabriele Feigelman
Elina Simanovich
Phillipp Brockmeyer
Michal A. Rahat

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374088

Original Research

Published on 25 Apr 2024

Signatures of CD4+ T and B cells are associated with distinct stages of chronic chagasic cardiomyopathy

in Parasite Immunology

Isabela Natália Pascoal Campos do Vale
Gregório Guilherme Almeida
Inga Rimkute
Thomas Liechti
Fernanda Fortes de Araújo
Luara Isabela dos Santos
Priscilla Miranda Henriques
Manoel Otávio da Costa Rocha
Silvana Maria Elói-Santos
Olindo Assis Martins−Filho

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385850

121 views

Navigation group

Articles

To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment

Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor

The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study

Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer

Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study

Exploring disease-specific metabolite signatures in hereditary angioedema patients

Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies

Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs

Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion

KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes’ phenotypes

Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges

Exosomal PD-L1 in cancer and other fields: recent advances and perspectives

Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems

EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells

Signatures of CD4+ T and B cells are associated with distinct stages of chronic chagasic cardiomyopathy